Literature DB >> 1713970

Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells.

B L Hsi1, J S Hunt, J P Atkinson.   

Abstract

Trophoblast cells forming the reactive interface between the mother and her semiallogeneic fetus risk attack by cellular and humoral elements of the maternal immune system. Biochemical, molecular, and immunohistologic studies have identified membrane cofactor protein (MCP) and decay accelerating factor (DAF) on trophoblast cells, which could assist in preventing lysis of the cells by complement-activating maternal antibodies. In this immunocytochemical study, differential expression of these two members of the family of complement regulatory proteins on subpopulations of human trophoblast cells and other types of cells in first and third trimester placentas was demonstrated. Staining with anti-MCP was particularly strong on villous cytotrophoblast cells and giant cells in first trimester tissues in comparison with other types of cells. In contrast, staining with anti-DAF was strong on proliferating cytotrophoblast in first trimester tissues, and on basal plate cytotrophoblast and decidual cells in term tissues. Placental villous mesenchymal cells but not trophoblast cells expressed a third regulatory protein, complement receptor 1. These observations support the postulate that complement regulatory proteins are critical to protection of the fetal allograft, and suggest specific requirements for trophoblast cells according to stage of differentiation and anatomic location.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713970     DOI: 10.1016/0165-0378(91)90036-p

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  22 in total

1.  Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies.

Authors:  Dorrith Schonkeren; Marie-Louise van der Hoorn; Padmini Khedoe; Godelieve Swings; Els van Beelen; Frans Claas; Cees van Kooten; Emile de Heer; Sicco Scherjon
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 2.  Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates.

Authors:  Ravid Shechter; Anat London; Michal Schwartz
Journal:  Nat Rev Immunol       Date:  2013-03       Impact factor: 53.106

Review 3.  The Microbiome and Complement Activation: A Mechanistic Model for Preterm Birth.

Authors:  Alexis B Dunn; Anne L Dunlop; Carol J Hogue; Andrew Miller; Elizabeth J Corwin
Journal:  Biol Res Nurs       Date:  2017-01-11       Impact factor: 2.522

Review 4.  Complement activation, a threat to pregnancy.

Authors:  Guillermina Girardi
Journal:  Semin Immunopathol       Date:  2017-09-12       Impact factor: 9.623

5.  Normal pregnancy is characterized by systemic activation of the complement system.

Authors:  Karina Richani; Eleazar Soto; Roberto Romero; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Samuel Edwin; Yeon Mee Kim; Joon-Seok Hong; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2005-04

Review 6.  Complement in human reproduction: activation and control.

Authors:  I A Rooney; T J Oglesby; J P Atkinson
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

7.  Production of interferons in human placental trophoblast subpopulations and their possible roles in pregnancy.

Authors:  G Aboagye-Mathiesen; F D Tóth; M Zdravkovic; P Ebbesen
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

Review 8.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

Review 9.  Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance.

Authors:  Chong Jai Kim; Roberto Romero; Piya Chaemsaithong; Jung-Sun Kim
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

Review 10.  Complement activation and pregnancy failure.

Authors:  Angela Tincani; Ilaria Cavazzana; Tamara Ziglioli; Andrea Lojacono; Valentina De Angelis; Pierluigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.